Comparative Clinicopathologic Characteristics and Outcomes of Paediatric and Adult Xp11 Translocation Renal Cell Carcinomas: a Retrospective Multicentre Study in China

[1]  Dongmei Li,et al.  PRCC-TFE3 dual-fusion FISH assay: A new method for identifying PRCC-TFE3 renal cell carcinoma in paraffin-embedded tissue , 2017, PloS one.

[2]  Hong-cheng Song,et al.  Nephron-sparing surgery in the treatment of pediatric renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusions. , 2017, Journal of pediatric surgery.

[3]  R. Autorino,et al.  Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies. , 2017, European urology.

[4]  Hongqian Guo,et al.  Clinical characteristics of XP11.2 translocation/TFE3 gene fusion renal cell carcinoma: a systematic review and meta-analysis of observational studies , 2016, BMC Urology.

[5]  S. McGuire.  World Cancer Report 2014. Geneva, Switzerland: World Health Organization, International Agency for Research on Cancer, WHO Press, 2015. , 2016, Advances in nutrition.

[6]  N. Masumori,et al.  Clinicopathological characteristics of Xp11.2 translocation renal cell carcinoma in adolescents and adults: Diagnosis using immunostaining of transcription factor E3 and fluorescence in situ hybridization analysis , 2016, International journal of urology.

[7]  Xiao-jun Zhou,et al.  [Renal cell carcinoma with t(6;11)(p21.2;q13)/MALAT1-TFEB fusion: a clinical and pathological analysis]. , 2015, Zhonghua bing li xue za zhi = Chinese journal of pathology.

[8]  A. Naranjo,et al.  Characterization of adolescent and pediatric renal cell carcinoma: A report from the Children's Oncology Group study AREN03B2 , 2015, Cancer.

[9]  Mark W. Ball,et al.  Partial nephrectomy for the treatment of translocation renal cell carcinoma. , 2015, Clinical genitourinary cancer.

[10]  Hongqian Guo,et al.  Newly Designed Break-Apart and ASPL-TFE3 Dual-Fusion FISH Assay Are Useful in Diagnosing Xp11.2 Translocation Renal Cell Carcinoma and ASPL-TFE3 Renal Cell Carcinoma , 2015, Medicine.

[11]  Jun Yang,et al.  Pseudocapsule of renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion: a clue for tumor enucleation? , 2015, International journal of clinical and experimental pathology.

[12]  Jun Yang,et al.  [Application of polyclonal break-apart probes in the diagnosis of Xp11.2 translocation renal cell carcinoma]. , 2014, Zhonghua yi xue za zhi.

[13]  Hong-cheng Song,et al.  Biological characteristics of pediatric renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions. , 2014, Journal of pediatric surgery.

[14]  D. Grignon,et al.  TFE3 Break-apart FISH Has a Higher Sensitivity for Xp11.2 Translocation–associated Renal Cell Carcinoma Compared With TFE3 or Cathepsin K Immunohistochemical Staining Alone: Expanding the Morphologic Spectrum , 2013, The American journal of surgical pathology.

[15]  J. Cheville,et al.  TFE3 Rearrangements in Adult Renal Cell Carcinoma: Clinical and Pathologic Features With Outcome in a Large Series of Consecutively Treated Patients , 2012, The American journal of surgical pathology.

[16]  C. Pan,et al.  Review of renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions with focus on pathobiological aspect. , 2012, Histology and histopathology.

[17]  A. Zlotta,et al.  Altered transcription factor E3 expression in unclassified adult renal cell carcinoma indicates adverse pathological features and poor outcome , 2011, BJU international.

[18]  P. Argani,et al.  Translocation renal cell carcinoma , 2008, Cancer.

[19]  M. Ladanyi,et al.  Xp11 Translocation Renal Cell Carcinoma in Adults: Expanded Clinical, Pathologic, and Genetic Spectrum , 2007, The American journal of surgical pathology.

[20]  A. Pappo,et al.  Pediatric renal cell carcinoma: clinical, pathologic, and molecular abnormalities associated with the members of the mit transcription factor family. , 2006, American journal of clinical pathology.

[21]  Antonio Lopez-Beltran,et al.  2004 WHO classification of the renal tumors of the adults. , 2006, European urology.

[22]  J. Dome,et al.  Local lymph node involvement does not predict poor outcome in pediatric renal cell carcinoma , 2004, Cancer.

[23]  A. Novick,et al.  Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. , 2000, The Journal of urology.

[24]  J. Oosterhuis,et al.  Cytogenetics of a renal adenocarcinoma in a 2-year-old child. , 1986, Cancer genetics and cytogenetics.

[25]  Q. Rao,et al.  Xp11 Translocation Renal Cell Carcinoma and the Mesenchymal Counterparts: An Evolving Concept with Novel Insights on Clinicopathologic Features, Prognosis, Treatment, and Classification. , 2017, Critical reviews in oncogenesis.

[26]  W. Liang,et al.  Xp11 translocation renal cell carcinoma in adults: a clinicopathological and comparative genomic hybridization study. , 2014, International journal of clinical and experimental pathology.

[27]  M. Picken,et al.  Xp11.2 translocation renal cell carcinoma with very aggressive course in five adults. , 2007, American journal of clinical pathology.